Publications by authors named "Mert Basaran"

Claim this Profile
T
Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study.
Zehra Sucuoğlu İşleyen, Seval Ay, Ertuğrul Bayram, Şaban Seçmeler, Oğuzhan Selvi

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma.
Hasan Cagri Yildirim, Ertuğrul Bayram, Elvin Chalabiyev, Nargız Majidova, Tugay Avci, Mert Basaran

J Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of extended [Lu] Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued?
Edanur Topal, Bilal Kovan, Ayca İribas, Serkan Kuyumcu, Mert Basaran

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer.
Hatice Bolek, Cagatay Arslan, Mert Basaran, İrfan Cicin, Mustafa Ozguroglu

JCO Glob Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort.
Kübra Özkaya Toraman, Rasim Meral, Ahmet Nafiz Karadeniz, Gizem Kaval, Mert Başaran

J Chemother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sorafenib in adult metastatic osteosarcoma patients.
Izzet Dogan, Nail Paksoy, Mert Basaran

J Cancer Res Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of high-dose chemotherapy with autologous stem-cell transplantation in 44 relapsed or refractory germ-cell tumor patients: A retrospective cohort study.
Ferhat Ferhatoglu, Nail Paksoy, Nijat Khanmammadov, Anil Yildiz, Melin Aydan Ahmed, Mert Basaran

Medicine (Baltimore)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients.
Izzet Dogan, Nail Paksoy, Mert Basaran

J Cancer Res Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey.
Arif Akyildiz, Deniz Can Guven, Ahmet Anil Ozluk, Rashad Ismayilov, Emel Mutlu, Mert Basaran

Medicine (Baltimore)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of second-line treatments in metastatic renal cell carcinoma patients: A single-center experience.
Metin Pehlivan, Nail Paksoy, Esra Aydin, Mert Basaran, Meltem Ekenel

Medicine (Baltimore)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma.
Izzet Dogan, Ayca Iribas, Melin Aydan Ahmed, Mert Basaran

J Chemother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of COVID-19 Disease on DNA Damage, Oxidative Stress and Immune Responses.
M Mert Basaran, Merve Hazar, Mehtap Aydın, Gülsüm Uzuğ, İlkima Özdoğan, Nursen Basaran

Toxics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course and features of soft tissue sarcomas in geriatric patients: a single-center experience.
Metin Pehlivan, Ayça İribaş, Bilge Bilgiç, Mert Başaran, Meltem Ekenel

J Int Med Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases.
Izzet Dogan, Ayca Iribas, Nail Paksoy, Sezai Vatansever, Mert Basaran

J Cancer Res Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing's sarcoma: A single institution experience.
Nail Paksoy, Ferhat Ferhatoglu, İzzet Dogan, Nijat Khanmammadov, Ayca Iribas Celik

Medicine (Baltimore)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of 177 Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters : A Single-Center Experience.
Duygu Has Simsek, Serkan Kuyumcu, Seyfullah Karadogan, Zeynep Gozde Ozkan, Emine Goknur Isik, Mert Basaran

Clin Nucl Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1.
Marleen J Meyer, Pascale C F Schreier, Mert Basaran, Stefaniia Vlasova, Tina Seitz

J Biol Chem· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
Nail Paksoy, Selcuk Erdem, Mert Karaca, Naziye Ak, Metin Pehlivan, Mert Basaran

J Oncol Pharm Pract· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
225Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: A Single-Center Experience.
Yasemin Sanli, Serkan Kuyumcu, Duygu Has Simsek, Fikret Büyükkaya, Caner Civan, Mert Basaran

Clin Nucl Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?
Ebru Yilmaz, Müge Nur Engin, Zeynep Gözde Özkan, Bilal Kovan, Fikret Büyükkaya

Nucl Med Commun· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy.
Ibrahim Yildiz, Ahmet Bilici, Nuri Karadurmuş, Leyla Ozer, Deniz Tural, Mert Basaran

Tumori· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Middle East observational study in metastatic soft tissue sarcoma: an epidemiological study on the treatment patterns (MOON).
Muhammad A Memon, Burcak Karaca, Rasha Aboelhassan, Mohsen Barsoum, Mustafa Erman, Mert Basaran

J Cancer Res Clin Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
22-year survival following radical nephrectomy and several metastasectomies in a case of renal cell carcinoma.
Ömer Barış Yücel, Hayri Murat Tunç, Mert Başaran, Necdet Aras

Turk J Urol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.
Petri Bono, Stephane Oudard, Istvan Bodrogi, Thomas E Hutson, Bernard Escudier, Mert Basaran

Clin Genitourin Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal cell cancer: overview of the current therapeutic landscape.
Mustafa Erman, Mustafa Benekli, Mert Basaran, Sevil Bavbek, Suleyman Buyukberber

Expert Rev Anticancer Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis